AIM ImmunoTech Statistics
NYSE: AIMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.18+0.0004 (+0.22%)
At close: Oct 9, 3:59 PM ET · Delayed 15 min
After hours: 0.18 0.00%
AIM ImmunoTech by the numbers
AIM ImmunoTech has a market capitalization of $7.2 million based on 39.89M shares outstanding. With trailing EPS of $-2.98, AIM ImmunoTech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.9% below its 50-day average and 68.6% below its 200-day average.
Average daily trading volume is 4.70M shares, or about $846,553 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AIM valuation vs. peer median
| Metric | AIM | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.18M | $4.70M | +53% |
| Avg. volume | 4.70M | 3.21M | +46% |
Peer median across 8 companies: BTTC, CELZ, LIMN, SNTI, PMCB, CLDI, SLXN, VIVS.
Valuation
- Market cap
- $7.18M
- EPS (TTM)
- $-2.98
- Shares outstanding
- 39.89M
Price and trading
- Previous close
- 0.1796
- Open
- 0.181
- Day range
- 0.177 – 0.183
- 52-week range
- 0.17 – 2.79
- 50-day moving average
- 0.2276
- 200-day moving average
- 0.5731
- Beta
- —
- Volume
- 402.98K
- Average volume
- 4.70M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 1, 2025
Additional statistics
- Market Cap
- 7.18M
- Forward Pe
- -0.49
- Eps
- -2.98
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.79
- Week52 Low
- 0.17
- Avg Volume
- 4.70M
- Shares Outstanding
- 39.89M
- Ma50
- 0.23
- Ma200
- 0.57
- Earnings Date
- Apr 1, 2025
- Pct From52w High
- -93.56%
- Pct From52w Low
- 5.88%